These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23884083)

  • 21. Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody.
    Cao M; Parthemore C; Jiao Y; Korman S; Aspelund M; Hunter A; Kilby G; Chen X
    J Pharm Sci; 2021 Aug; 110(8):2904-2915. PubMed ID: 33894207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
    Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
    Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains.
    Tous GI; Wei Z; Feng J; Bilbulian S; Bowen S; Smith J; Strouse R; McGeehan P; Casas-Finet J; Schenerman MA
    Anal Chem; 2005 May; 77(9):2675-82. PubMed ID: 15859580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of product-related low molecular weight impurities in therapeutic monoclonal antibodies using hydrophilic interaction chromatography coupled with mass spectrometry.
    Wang S; Liu AP; Yan Y; Daly TJ; Li N
    J Pharm Biomed Anal; 2018 May; 154():468-475. PubMed ID: 29587227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies.
    Xie H; Chakraborty A; Ahn J; Yu YQ; Dakshinamoorthy DP; Gilar M; Chen W; Skilton SJ; Mazzeo JR
    MAbs; 2010; 2(4):379-94. PubMed ID: 20458189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid identification of an antibody DNA construct rearrangement sequence variant by mass spectrometry.
    Scott RA; Rogers R; Balland A; Brady LJ
    MAbs; 2014; 6(6):1453-63. PubMed ID: 25484040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometry.
    Yin Y; Han G; Zhou J; Dillon M; McCarty L; Gavino L; Ellerman D; Spiess C; Sandoval W; Carter PJ
    MAbs; 2016; 8(8):1467-1476. PubMed ID: 27610742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational selection of building blocks for the assembly of bispecific antibodies.
    Gong D; Riley TP; Bzymek KP; Correia AR; Li D; Spahr C; Robinson JH; Case RB; Wang Z; Garces F
    MAbs; 2021; 13(1):1870058. PubMed ID: 33397191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interaction.
    Elliott JM; Ultsch M; Lee J; Tong R; Takeda K; Spiess C; Eigenbrot C; Scheer JM
    J Mol Biol; 2014 May; 426(9):1947-57. PubMed ID: 24576605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Structure verification of a recombinant chimeric anti-CD20 IgG1 monoclonal antibody].
    Tao L; Rao CM; Gao K; Shi XC; Zhao Y; Wang JZ
    Yao Xue Xue Bao; 2010 Jun; 45(6):752-5. PubMed ID: 20939185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysis.
    Shi RL; Xiao G; Dillon TM; Ricci MS; Bondarenko PV
    MAbs; 2020; 12(1):1739825. PubMed ID: 32292112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing antibody Fc heterodimer formation through electrostatic steering effects: applications to bispecific molecules and monovalent IgG.
    Gunasekaran K; Pentony M; Shen M; Garrett L; Forte C; Woodward A; Ng SB; Born T; Retter M; Manchulenko K; Sweet H; Foltz IN; Wittekind M; Yan W
    J Biol Chem; 2010 Jun; 285(25):19637-46. PubMed ID: 20400508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design.
    Von Kreudenstein TS; Escobar-Carbrera E; Lario PI; D'Angelo I; Brault K; Kelly J; Durocher Y; Baardsnes J; Woods RJ; Xie MH; Girod PA; Suits MD; Boulanger MJ; Poon DK; Ng GY; Dixit SB
    MAbs; 2013; 5(5):646-54. PubMed ID: 23924797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells.
    Joshi KK; Phung W; Han G; Yin Y; Kim I; Sandoval W; Carter PJ
    MAbs; 2019 Oct; 11(7):1254-1265. PubMed ID: 31286843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical characterization of IgG Fc subclass variants through high-resolution separation combined with multiple LC-MS identification.
    He XA; Washburn N; Arevalo E; Robblee JH
    Anal Bioanal Chem; 2015 Sep; 407(23):7055-66. PubMed ID: 26231686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sheathless CE-MS as a tool for monitoring exchange efficiency and stability of bispecific antibodies.
    Gstöttner C; Vergoossen DLE; Wuhrer M; Huijbers MGM; Domínguez-Vega E
    Electrophoresis; 2021 Jan; 42(1-2):171-176. PubMed ID: 32901958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput antibody screening from complex matrices using intact protein electrospray mass spectrometry.
    Sawyer WS; Srikumar N; Carver J; Chu PY; Shen A; Xu A; Williams AJ; Spiess C; Wu C; Liu Y; Tran JC
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9851-9856. PubMed ID: 32327606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyroglutamate and O-linked glycan determine functional production of anti-IL17A and anti-IL22 peptide-antibody bispecific genetic fusions.
    Zhong X; Kieras E; Sousa E; D'Antona A; Baber JC; He T; Desharnais J; Wood L; Luxenberg D; Stahl M; Kriz R; Lin L; Somers W; Fitz LJ; Wright JF
    J Biol Chem; 2013 Jan; 288(2):1409-19. PubMed ID: 23184956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry.
    Xie H; Gilar M; Gebler JC
    Anal Chem; 2009 Jul; 81(14):5699-708. PubMed ID: 19518054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
    Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
    Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.